Global Radioisotopes in Medicine Market Growth 2023-2029

Global Radioisotopes in Medicine Market Growth 2023-2029

The global Radioisotopes in Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Radioisotopes in Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Radioisotopes in Medicine players cover NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.

LPI (LP Information)' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2023 through 2029. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.

This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radioisotopes in Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Others

Segmentation by application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
SHINE Technologies
NorthStar Medical Radioisotopes

Key Questions Addressed in this Report

What is the 10-year outlook for the global Radioisotopes in Medicine market?

What factors are driving Radioisotopes in Medicine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Radioisotopes in Medicine market opportunities vary by end market size?

How does Radioisotopes in Medicine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.